STOCK TITAN

SciSparc (SPRC) director Revach Moshe discloses initial share and RSU holdings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

SciSparc Ltd. director Revach Moshe filed an initial ownership report showing direct holdings of 3,651 Ordinary Shares and stock options over 1 Ordinary Share that are fully vested as of April 21, 2024.

The filing also notes future equity rights from restricted share units. These include 3,333 Ordinary Shares vesting in equal quarterly installments of 417 shares beginning on March 18, 2026, and 120 Ordinary Shares vesting in equal quarterly installments of 15 shares beginning on September 30, 2024, with each RSU delivering one Ordinary Share at vesting.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Revach Moshe

(Last)(First)(Middle)
20 RAUL WALLENBERG STREET
TOWER A, TEL AVIV, ISRAEL

(Street)
TEL AVIV6971916

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
SciSparc Ltd. [ SPRC ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares3,651(1)D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock option (right to buy)03/01/202203/01/2028Ordinary Shares1(2)$21,294D
Explanation of Responses:
1. Includes (i) 3,333 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") in equal quarterly installments of 417 Ordinary Shares beginning on March 18, 2026; and (ii) 120 Ordinary Shares issuable upon the vesting of RSUs in equal quarterly installments of 15 Ordinary Shares beginning on September 30, 2024. Each RSU represents the right to receive one Ordinary Share.
2. Fully vested on April 21, 2024.
/s/ Moshe Revach03/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does SciSparc (SPRC) director Revach Moshe report in this Form 3?

Revach Moshe reports initial ownership of 3,651 Ordinary Shares of SciSparc and fully vested stock options over 1 Ordinary Share. The filing also discloses additional rights to receive shares through restricted share units vesting over time.

How many SciSparc (SPRC) RSUs does Revach Moshe have and how do they vest?

The filing shows 3,333 RSUs vesting in quarterly installments of 417 shares from March 18, 2026, and 120 RSUs vesting in quarterly installments of 15 shares from September 30, 2024. Each RSU converts into one Ordinary Share at vesting.

What stock options does Revach Moshe hold in SciSparc (SPRC)?

Revach Moshe holds a stock option to acquire 1 Ordinary Share with an exercise price of 21,294.0000, expiring on March 1, 2028. A footnote states this option was fully vested on April 21, 2024, meaning it is fully exercisable.

Is this SciSparc (SPRC) Form 3 reporting a new transaction or just holdings?

This Form 3 reports existing holdings and equity awards rather than clear buy or sell transactions. It lists shares, stock options, and RSUs that define the director’s current and future ownership position, serving as a baseline disclosure of insider holdings.

How many SciSparc (SPRC) Ordinary Shares does Revach Moshe own directly?

The Form 3 states that Revach Moshe directly owns 3,651 Ordinary Shares following the reported holdings. This figure excludes additional shares that may be issued later from his vested stock option and from RSUs that vest over future quarters.
Scisparc

NASDAQ:SPRC

View SPRC Stock Overview

SPRC Rankings

SPRC Latest News

SPRC Latest SEC Filings

SPRC Stock Data

2.62M
453.27k
Biotechnology
Healthcare
Link
Israel
Tel Aviv-Yafo